
Another PLI scheme hits the Chinese wall, as India now mulls extension for projects under solar module incentive scheme
New Delhi: The government is considering extending the deadline for completion of projects under the Production Linked Incentive (PLI) scheme for solar modules and their parts, said two people in the know of the development, amid delays in technology sourcing and component supply from China.
The ₹19,500 crore scheme for fully and partially integrated solar PV module manufacturing has scheduled commissioning dates from October 2024 to April 2026.
Data from the ministry of new and renewable energy showed that around 17.5 GW of module manufacturing capacity had been completed by First Solar, Avaada, Grew, Tata Power Solar and Indosol, out of the awarded 48.3 GW awarded to several companies.
Also read: India's power demand to grow 5.5% in FY26: Icra
Of the 44.9 GW cell manufacturing capacity awarded to several companies, only 6 GW has been completed by Tata Power Solar and ReNew.
In terms of ingot and wafer manufacturing, only 2 GW capacity has been completed by Adani Group, out of the overall 37.5 GW awarded capacity.
'A key reason of the delay has been lack in supply of components and technology transfer from China, and also the curb on travel of technicians from there," said an industry executive on the condition of anonymity.
The ministry of new and renewable energy (MNRE) is in talks with the finance ministry for extension of the deadline after the industry reached out to the government with a similar request.
'The extension may be given on a case-by-case basis and wherever the issues pertain to supply chain constraints. The talks are underway between MNRE and finance ministry and a final decision is yet to be taken," said one of the two people mentioned above.
Also read: BEML plans to develop light infantry vehicles, future-ready combat vehicles
Industry players in the past few months have also reached out to the ministry of external affairs (MEA) to relax visa restrictions for technicians which have also impacted the project implementation. But so far the issue has not been resolved amid national security concerns, added the industry executive mentioned above.
'The MEA has also been given some specific names of required technicians who need to travel, but approvals have not come yet," the executive said.
Queries mailed to the MNRE, MEA, Adani Group, Avaada Group, Reliance Industries and Indosol remained unanswered till press time.
Another executive with a module manufacturer under the PLI scheme said: 'India currently remains entirely dependent on imports for equipment and critical materials for module manufacturing and is vulnerable to global supply chain disruptions and price fluctuations. Also, travel restrictions linked to engineering and equipment adversely impacted execution planning leading to further delays. Since most of the critical materials are made to order, any delays in placing orders will push the delivery timelines further."
The executive added that current global tariff and trade dynamics have affected supply chains and led to uncertainty in placing orders for equipment leading to delays to timelines.
However, Amit Paithankar, whole-time director and chief executive officer, Waaree Energies Ltd, said: 'Our PLI-supported project is on track. Various stages of the project—including engineering and procurement—are progressing as planned. While there were some initial delays due to supply chain constraints and the availability of trained manpower (both within India and internationally), these issues have now been addressed and the project is moving forward smoothly."
Solar component manufacturing has been a key focus area for the government as India aims to reduce import dependence from China. Although in the past few years India has significantly grown its module and other component manufacturing, the lack of supplies of sub-components and technical assistance from China has in the past couple of years impacted the domestic manufacturing.
The government has also imposed tariff and non-tariff barriers on solar modules including high basic customs duty and an Approved List of Models and Manufacturers for supply of modules to government-backed projects.
Further, earlier this year, the MNRE said it will introduce a similar list for solar cells starting June 2026.
In December 2024, the finance ministry imposed a provisional anti-dumping duty on textured, tempered, coated and uncoated solar glass imports from China in the range of $673-677 per tonne and $565 per tonne for imports from Vietnam. Following this the price of solar photovoltaic (PV) modules increased by 10-12%.
Mint in January wrote that the increase in prices has raised concerns among industry participants over project cost escalations and potential delays.
Also read: ONGC-led JV resumes production from 'PY-3' offshore field in Cauvery basin
Currently, the country has about 80 GW of module manufacturing capacity including those under the PLI scheme, according to MNRE data. India's cell and wafer manufacturing capacity stands at 25GW and 2GW respectively. The Centre aims to have an installed capacity of 100GW for cells and 40GW for wafers by 2030 and also become an export hub.
Indian manufacturers are also exporting modules, with the US being the largest procurer. As India aims to become a manufacturing hub for renewable energy components, the Centre is also pursuing direct government-to-government engagements with African and West Asian nations to open new markets for Indian green energy firms and solar equipment manufacturers.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


United News of India
an hour ago
- United News of India
FS Misri, UK Permanent Under Secretary Robbins co-chair Foreign Office Consultations
New Delhi, June 3 (UNI) Foreign Secretary Vikram Misri and UK Permanent Under Secretary Oliver Robbins today co-chaired the 17th India-UK Foreign Office Consultations and 1st Strategic Exports and Technology Cooperation Dialogue during which they focused on further deepening and diversifying the India-UK Comprehensive Strategic Partnership. The MEA spokesperson in a post on X said that Foreign Secretary Miri thanked the UK Government for their expression of solidarity and support to India in the fight against terrorism. '17th India-UK Foreign Office Consultations and 1st Strategic Exports and Technology Cooperation Dialogue co-chaired by Foreign Secretary @VikramMisri and Permanent Under Secretary @Ollyrobbins were held in New Delhi. 'Wide ranging discussions on entire gamut of bilateral relations focusing on further deepening & diversifying India-UK Comprehensive Strategic Partnership in areas of Trade & Economy, Technology, Science, Innovation, Defence & Security, Education, Health & Climate & People-to-People exchanges took place. They also discussed the regional & global issues of topical significance. 'Foreign Secretary thanked UK Government for expression of solidarity and support to India in fight against terrorism.' The UK, in a readout, said the two sides 'welcomed the significant breakthroughs achieved across the full breadth of the partnership since consultations in London last year, including the announcement of the historic trade deal. Economic growth is the number one mission of the UK Government. Both agreed to work towards implementing the shared vision of the two prime ministers for an ambitious partnership between the UK and India over the next decade.' This year's consultations included the inaugural Strategic Exports and Technology Cooperation Dialogue, aimed at building mutual understanding of systems and agreeing on areas for future cooperation on key sectors such as technology and defence, the UK High Commission said in a statement. Oliver Robbins, Permanent Under-Secretary at the FCDO, said: 'I'm delighted to be in India to help advance one of the UK's most vital partnerships in the world. In a more complex world, there is strong ambition from both governments to take this partnership to even greater heights.' UNI RN


Mint
6 hours ago
- Mint
India bulks up its drugs PLI scheme in renewed pushback against Chinese imports
New Delhi: India is looking to give a significant boost to its production-linked incentives for drug manufacturing, particularly in terms of its ambition to reduce the domestic pharmaceutical industry's dependence on China for its raw materials. The upgraded PLI scheme will include more molecules used in manufacturing key starting materials (KSMs), drug intermediates, and active pharmaceutical ingredients (APIs), according to a communication issued on 14 May by the department of pharmaceuticals, which Mint has reviewed. Details such as allocation, capacity, and incentive ceiling for the upgraded drug PLI scheme are being worked on, adepartment official said, declining to be identified. Key starting materials and drug intermediates are chemical compounds used to synthesise APIs, or bulk drugs, which are the main components of a drug providing its intended medical effect. India's API industry is a crucial segment of its overall pharmaceutical sector, accounting for about 35% of the market, according to Invest India. But the domestic pharmaceutical industry is dependent on imports for 80% of its bulk drug requirement. This is also because a significant chunk of the domestic production is meant for overseas markets. In 2024-25, India imported bulk drugs and advanced drug intermediates worth $3.5 billion, while exports accounted for nearly $3.5 billion, according to India's commerce ministry. About 65% of the imports came from China. In 2023-24, the exports were higher at $4.79 billion while the imports were at $4.56 billion. For the upgraded PLI scheme, the department of pharmaceuticals has sought applications for manufacturing raw materials required to produce life-saving antibiotics, antifungal drugs, and medicines used in the treatment of diseases such as epilepsy and diabetes. 'As per the decision taken, conditions under the scheme such as allocation according to the available capacities, incentive ceiling in respect of products and limit of incentive upto production tenure i.e. upto FY2027-28, for chemical synthesis products and upto FY2028-29 for fermentation-based products, have to be complied with," the department of pharmaceuticals said in its notice. The department of pharmaceutical's secretary, Amit Agarwal, and its spokesperson did not reply to queries emailed on 1 June. Also read | India puts big pharma concessions on table as US trade deal nears finish line 'Need protection from China' The Central government launched PLI schemes in 2020 for domestic manufacturing of drugs with a financial outlay of ₹6,940 crore, chiefly to cut the industry's reliance on China. The production tenure for those PLI schemes stretches from 2022-2023 to 2028-29. Currently, the government has 14 PLI schemes in play for India's pharmaceutical sector, including for medical devices, pharmaceuticals, and bulk drugs. According to the government, under the PLI scheme for bulk drugs, 48 projects have been selected, of which 34 have been commissioned for 25 bulk drugs. The scheme has helped domestic pharma companies begin production of key drug ingredients such as penicillin G and clavulanic acid that are used in manufacturing antibiotics including amoxicillin. '(But) there are certain drugs in the existing or previous PLI scheme for bulk drugs/APIs which are unviable even after considering incentives under PLI," said R.K. Agrawal, national president, Bulk Drugs Manufacturers Association of India. 'Industry is also not finding solution/safe guards to Chinese dumping of these products in future as the 10% incentive provided under the scheme will not be able to protect the industry. DoP (the department of pharmaceuticals) is trying to seek industry interest in the same products and providing one more opportunity," Agrawal said. Also read | India tightens export rules for medicines to check wide misuse as narcotics in overseas markets A director at a company that participated in the existing PLI scheme for bulk drugs said that despite investing heavily in producing an important API, including establishing a manufacturing facility for it, the firm was going into losses. 'Right now, we are selling out products at a 30% loss. China has reduced the price of its raw materials or APIs by 40%, and people are buying from China even though products are available domestically," the director said, speaking on condition of anonymity. 'We made our representation to the government that we need protection from China. The government has now created a strategy where they are practically going to implement the minimum import price on China to defend the previous PLI scheme, the product for which we have won the PLI," the director added. Also read | ICMR gets a breakthrough in attempts to develop first indigenous Nipah virus medicine A growing domestic industry Given India's growing lifestyle-related disease burden, the domestic pharma industry uses bulk drugs largely in manufacturing antibiotics to manage non-communicable diseases such as cardiovascular diseases, chronic respiratory diseases, and diabetes. India's API market is projected to reach $22 billion by 2030, growing at a compound annual growth rate of 8.3%, according to consulting firm Praxis Global Alliance. Viranchi Shah, national spokesperson, Indian Drugs Manufacturer Association, said that under its upgraded PLI scheme, the government wants to cover molecules for which manufacturing capabilities need to be strengthened and where India's capabilities are underutilized. Pharmaceutical products such as neomycin, erythromycin thiocyanate, and gentamycin will be covered under the new PLI scheme, as per the department of pharmaceuticals' notice. India's pharmaceutical industry is poised for significant growth, Shah said, adding that PLI schemes promoting domestic production of key APIs and KSMs had been 'largely successful". Also read | With state hospitals' essential medicine stock at less than 40%, Centre sounds alarm bells 'Last year, the export of API exceeded the import of API. Certain very critical ingredients, a precursor of paracetamol, para amino phenol (PAP), was manufactured in a very small quantity. When covid-19 struck in 2020, we (India) had only one plant and all the other requirements were imported. Today, we have three plants in India. So the import of PAP has considerably gone down, which results in a better supply chain for paracetamol," Shah said. 'Clavulanic acid was never produced in India but now (it is) being manufactured in India (and) used for antibiotics like augmentin. A very important molecule, Pen-g, used to be manufactured in India 25 years back, but slowly the industry vanished from India due to increasing capabilities in neighbouring countries. It is now being manufactured in India," he added.


Mint
8 hours ago
- Mint
Think ahead: India's electronics manufacturing must go up the value curve
India's smartphone exports stood at $10.96 billion in 2022-23 and surged to $24.14 billion in 2024-25, a striking compound annual growth rate (CAGR) of 48.4%. Long reliant on imports and peripheral to global value chains, India's electronics manufacturing is becoming a pillar for job creation, export growth and technological advancement. However, India must temper its excitement about labour-led electronics manufacturing growth and double down on boosting domestic value addition. The 'China plus one' strategy, accelerated by the pandemic and heightened US–China tensions, has led to supply chain diversification by global manufacturers. Among alternatives, India stands out thanks to its vast domestic market, improving infrastructure and large labour supply. India is the world's second-largest mobile phone making hub now, a status that reflects both expanding production and rising quality standards. It is also well placed to further capitalize on the 'friend-shoring' trend born of geopolitics. Also read: Centre mulls maximising electronics earnings amid uncertainty over Apple exports, tariff haze At the heart of our manufacturing drive is the government's production-linked incentive (PLI) scheme, which has attracted significant investments from global players. Apple, for instance, now assembles 10-12% of all iPhones in India. In 2024-25, iPhone exports amounted to $17.4 billion. Samsung runs the world's largest mobile phone factory in Noida, catering to both domestic and international markets. Beyond mobile phones, India's Semiconductor Mission, backed by a $10 billion outlay, aims to build a full-stack chip ecosystem, from fabrication units to assembly, testing, marking and packaging facilities, apart from design capabilities. This is critical given that semiconductors are India's second-largest import item after crude oil. Complementing these efforts is the Electronics Manufacturing Clusters scheme, which provides plug-and-play infrastructure, land and logistical support to manufacturers. India is also gaining momentum in display manufacturing, printed circuit board production, camera modules and power electronics. We must also seize the global data centre boom—not just as a digital infrastructure opportunity, but as a strategic lever for manufacturing. Surging worldwide demand for hyperscale data centres and AI infrastructure is rapidly enlarging markets for servers, cooling systems, power equipment and networking components—areas in which India can become globally competitive. By aligning industrial policy, export incentives and skilling programmes with the needs of global data centre operators, India can attract investment and position itself as a hardware manufacturing hub for digital infrastructure. A dual strategy of hosting global data and building the infrastructure that powers it could amplify India's economic prospects and influence. Electronics manufacturing is labour-intensive and could, over the next five years, generate over 1 million direct jobs, particularly in Tier 2 and Tier 3 cities. As domestic value chains deepen, micro, small and medium enterprises (MSMEs) could be integrated into global production networks. This would not only spread the benefits of industrial growth, but also help formalize and upgrade India's vast informal manufacturing base. Also read: Why India's electronics sector is least at risk from Trump's reciprocal tariff scrutiny Increasing value addition is the other challenge. In smartphone manufacturing, it has improved from 2% in 2014 to 15-16% in 2024, but still trails China's. Premium smartphones exported from India rely on 90-95% imported components. According to the Global Trade Research Institute, for every $1,000 worth of iPhones that India exports, we capture just $30—compared to $450 by the US and $150 by Taiwan. India ranks 44th on Harvard University's Economic Complexity Index, a measure of production sophistication, while China is 16th and Taiwan is 4th. Vietnam, ranked 48th, saw a tenfold surge in its manufacturing exports from 2000 to 2023. Yet, its domestic value addition has plateaued since 2010, offering us a cautionary example. Unlike China and Vietnam, India has not reached the 'Lewis Turning Point' at which developing economies exhaust their labour surpluses and wages begin to rise swiftly. This reflects structural challenges in our labour market. Until India reaches that point, it is easy to be misled by the apparent advantage of labour availability, without recognizing the pressing need to focus on value addition. For enduring economic growth, India must move up the production value chain and not remain merely a destination for low-value product assembly. We must invest in precision tooling, high-end materials and critical components manufacturing. Programmes like the Electronics Components Manufacturing Scheme are important steps, but both their scale and execution speed must increase significantly. We must also sharpen our focus on skilling and sustainability. Deeper investments in technical education and industry-academia collaboration are vital. While we must adopt globally recognized sustainability practices, our policies on issues like e-waste responsibility must be business-enabling and grounded in operational realities. Also read: Budget smartphones sell like hot cakes in tepid market India's electronics manufacturing journey is no longer an experiment—it is now a strategic economic growth pivot. If this momentum continues, the sector could contribute over $300 billion in annual output by 2030, create millions of jobs, boost exports and significantly strengthen India's technological and economic sovereignty. The author is a strategy and public policy professional. His X handle is @prasannakarthik